[1]
2026. SYSTEMATIC REVIEW OF THE EFFECTIVENESS AND SAFETY OF SUBCUTANEOUS SEMAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND OBESITY. Vietnam Journal of Community Medicine. 67, CĐ8-NCKH (July 2026). DOI:https://doi.org/10.52163/yhc.v67iCD8.5720.